viiv healthcare b.v. - cabotegravir - hiv Λοιμώξεις - Αντιιικά για συστηματική χρήση - apretude is indicated in combination with safer sex practices for pre-exposure prophylaxis (prep) to reduce the risk of sexually acquired hiv-1 infection in high-risk adults and adolescents, weighing at least 35 kg (see sections 4. 2, 4. 4 και 5.
Den europeiske union -
gresk -
EMA (European Medicines Agency)